Renerve (RNV.AX) Surges on Record Q1 Sales, Asia‑Pacific Expansion & New Funding
Renerve’s Q1 sales record, Indonesia approval, and RiverFort funding boost growth prospects for its NervAlign nerve cuff, positioning it ahead in Asia‑Pacific.
2 minutes to read